Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Formulation and Solubility

Christine Dufes's Biography



Christine Dufes, Senior Lecturer, University of Strathclyde

Christine Duf├Ęs is a Senior Lecturer at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow (United Kingdom). She obtained a Doctorate in Pharmacy (with Distinction and congratulations of the Jury) and a PhD (with a European Label, Distinction and congratulations of the Jury) from the University of Poitiers (France). After four years as a post-doctoral researcher at the Cancer Research UK Beatson Laboratories in Glasgow, she was appointed as a Lecturer at the Strathclyde Institute of Pharmacy and Biomedical Sciences in 2006 and became a Senior Lecturer in 2012. Her research interests include the targeted delivery of drugs and therapeutic genes to tumours and cerebral diseases. She has been awarded the Biochemical Journal Young Investigator Award (2009) and the Tom Gibson Memorial Award (2012) for her research, the Best Overall Strathclyde Teaching Excellence Award (2013) for her teaching. She sits on the editorial boards for the Chinese Journal of Clinicians, ISRN Pharmaceutics, Journal of Pharmaceutics and Pharmaceutical Nanotechnology, BioMed Research International, Advances in Biomaterials and is a Scientific Advisor to the Editors of Journal of Pharmaceutical Sciences.

Christine Dufes Image

Tumour Regression after Intravenous Administration of Novel Targeted Anti-cancer Therapeutic Systems

Tuesday, 19 March 2013 at 16:00

Add to Calendar ▼2013-03-19 16:00:002013-03-19 17:00:00Europe/LondonTumour Regression after Intravenous Administration of Novel Targeted Anti-cancer Therapeutic SystemsSELECTBIOenquiries@selectbiosciences.com

The possibility of using genes as medicines to treat cancer is limited by the lack of efficacious delivery systems able to selectively deliver genes to tumours. We demonstrated that the intravenous administration of a tumour-targeted dendriplex led to tumour disappearance of 90% of the tested tumours over one month.


Add to Calendar ▼2013-03-19 00:00:002013-03-20 00:00:00Europe/LondonFormulation and SolubilitySELECTBIOenquiries@selectbiosciences.com